- Home
- SEER vs COYA Comparison
SEER vs COYA Comparison
Compare SEER & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- COYA
- Stock Information
- Founded
- SEER 2017
- COYA 2020
- Country
- SEER United States
- COYA United States
- Employees
- SEER N/A
- COYA N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- SEER Health Care
- COYA Health Care
- Exchange
- SEER Nasdaq
- COYA Nasdaq
- Market Cap
- SEER 113.8M
- COYA 107.0M
- IPO Year
- SEER 2020
- COYA 2022
- Fundamental
- Price
- SEER $2.15
- COYA $5.61
- Analyst Decision
- SEER
- COYA Strong Buy
- Analyst Count
- SEER 0
- COYA 4
- Target Price
- SEER N/A
- COYA $16.50
- AVG Volume (30 Days)
- SEER 139.2K
- COYA 116.6K
- Earning Date
- SEER 11-05-2025
- COYA 11-05-2025
- Dividend Yield
- SEER N/A
- COYA N/A
- EPS Growth
- SEER N/A
- COYA N/A
- EPS
- SEER N/A
- COYA N/A
- Revenue
- SEER $16,288,000.00
- COYA $423,452.00
- Revenue This Year
- SEER $27.77
- COYA $40.80
- Revenue Next Year
- SEER $20.28
- COYA N/A
- P/E Ratio
- SEER N/A
- COYA N/A
- Revenue Growth
- SEER 10.52
- COYA N/A
- 52 Week Low
- SEER $1.62
- COYA $4.65
- 52 Week High
- SEER $2.63
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- SEER 57.91
- COYA 38.75
- Support Level
- SEER $2.03
- COYA $5.37
- Resistance Level
- SEER $2.11
- COYA $6.53
- Average True Range (ATR)
- SEER 0.06
- COYA 0.43
- MACD
- SEER 0.01
- COYA -0.12
- Stochastic Oscillator
- SEER 81.82
- COYA 15.89
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.